Ultra-low temperature storage of advanced therapy medicinal products: carbon footprint should be integrated into the selection criteria

Bertrand Pourroy

Open source

DOI
10.1016/j.pharma.2026.11.001
Published
2026-11
Container
Annales Pharmaceutiques Françaises
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pharma.2026.11.001,
  title = {Ultra-low temperature storage of advanced therapy medicinal products: carbon footprint should be integrated into the selection criteria},
  author = {Bertrand Pourroy},
  year = {2026},
  journal = {Annales Pharmaceutiques Françaises},
  doi = {10.1016/j.pharma.2026.11.001},
  url = {https://doi.org/10.1016/j.pharma.2026.11.001}
}

RIS

TY  - JOUR
TI  - Ultra-low temperature storage of advanced therapy medicinal products: carbon footprint should be integrated into the selection criteria
AU  - Bertrand Pourroy
PY  - 2026
JO  - Annales Pharmaceutiques Françaises
DO  - 10.1016/j.pharma.2026.11.001
UR  - https://doi.org/10.1016/j.pharma.2026.11.001
ER  - 

APA

Pourroy, B. (2026). Ultra-low temperature storage of advanced therapy medicinal products: carbon footprint should be integrated into the selection criteria. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.11.001

Source records